Pulmonary Function Testing (PFT) is a key tool in the diagnostic arsenal of respiratory medicine, providing vital information about lung function. Yet, the complexity of PFT interpretation often poses a challenge for healthcare professionals.
The core parameters of PFTs include Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), and the FEV1/FVC ratio. FVC represents the total amount of air exhaled forcefully after maximal inspiration. FEV1 is the volume exhaled during the first second of the FVC maneuver. The FEV1/FVC ratio is a useful index for detecting airway obstruction.
Interpretation involves assessing these parameters against predicted normal values. A reduced FEV1/FVC ratio (<70%) indicates obstructive lung disease. If FEV1 and FVC are proportionately reduced with a normal FEV1/FVC ratio, it suggests a restrictive pattern. Mixed defects show both obstructive and restrictive features.
Assessing bronchodilator response is crucial in diagnosing conditions like asthma. A significant increase in FEV1 or FVC post-bronchodilator administration indicates reversible airway obstruction, a hallmark of asthma.
DLCO measures the lung's ability to transfer gas from inhaled air to the red blood cells. Reduced DLCO may indicate interstitial lung disease, pulmonary vascular disease, or emphysema.
Decoding PFT results is a nuanced process, requiring a solid understanding of respiratory physiology and diseases. By understanding the key parameters and their implications, healthcare professionals can effectively use PFTs to diagnose, monitor, and manage respiratory conditions. Continued education and practice are essential to enhance proficiency in PFT interpretation.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation